• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
77,569.39 827.57
( 1.08%)
Global Indices
Nasdaq
52,658.24 149.83
(0.29%)
Dow Jones
7,594.79 30.15
(0.40%)
Hang Seng
68,634.11 890.26
(1.31%)
Nikkei 225
10,498.02 25.57
(0.24%)
Forex
USD-INR
95.45 -0.01
(-0.01%)
EUR-INR
109.10 0.17
(0.15%)
GBP-INR
127.94 0.35
(0.28%)
JPY-INR
0.59 0.00
(0.03%)

EQUITY - MARKET SCREENER

Sandu Pharmaceuticals Ltd
Industry :  Pharmaceuticals - Indian - Formulations
BSE Code
ISIN Demat
Book Value()
524703
INE751D01014
36.3372594
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
22.4
39.61
EPS(TTM)
Face Value()
Div & Yield %
1.83
10
2.44
 

Sandu Pharmaceuticals standalone net profit declines 87.88% in the March 2026 quarter
May 06,2026
Net profit of Sandu Pharmaceuticals declined 87.88% to Rs 0.04 crore in the quarter ended March 2026 as against Rs 0.33 crore during the previous quarter ended March 2025. Sales rose 19.76% to Rs 16.85 crore in the quarter ended March 2026 as against Rs 14.07 crore during the previous quarter ended March 2025.

For the full year,net profit rose 14.19% to Rs 1.77 crore in the year ended March 2026 as against Rs 1.55 crore during the previous year ended March 2025. Sales rose 4.08% to Rs 69.93 crore in the year ended March 2026 as against Rs 67.19 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales16.8514.07 20 69.9367.19 4
OPM %3.323.20 -4.304.11 -
PBDT0.900.49 84 3.342.83 18
PBT0.740.34 118 2.662.16 23
NP0.040.33 -88 1.771.55 14